Literature DB >> 23844477

Destruction of single-species biofilms of Escherichia coli or Klebsiella pneumoniae subsp. pneumoniae by dextranase, lactoferrin, and lysozyme.

Cynthia L Sheffield1, Tawni L Crippen, Toni L Poole, Ross C Beier.   

Abstract

The aim of this work was to determine the destructive activity of dextranase, lactoferrin, and lysozyme, against single species biofilms composed of either Klebsiella pneumoniae subsp. pneumoniae or Escherichia coli using the MBEC Assay. Luminescence measurements based on quantitation of the ATP present were used to determine the amount of biofilm elimination and correlated with quantity of live bacteria present in the sample. The data were analyzed employing a two-way ANOVA and Bonferroni post-test. Treatments resulted in percentage reductions of E. coli biofilms ranging from 73 to 98%. Lactoferrin (40 microg/ml) produced a significantly higher-percentage reduction than lysozyme (10 microg/ml) (P < 0.05), no other significant differences occurred. Similar treatments resulted in percentage reductions of K. pneumoniae subsp. pneumoniae biofilms ranging from 51 to 100%. Dextranase treatments produced a significantly lower percentage reduction than all other materials (P < 0.05), no other significant differences occurred. No material was capable of complete destruction of both single species biofilms; however, low concentrations of lactoferrin and lysozyme each removed 100% of the K. pneumoniae subsp. pneumoniae biofilm. Low concentrations of lactoferrin or lysozyme might be beneficial to prevent biofilm formation by K. pneumoniae subsp. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23844477     DOI: 10.2436/20.1501.01.171

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  5 in total

1.  The Cationic Antimicrobial Peptide Activity of Lysozyme Reduces Viable Enterococcus faecalis Cells in Biofilms.

Authors:  Candace N Rouchon; Joann Harris; Zahra Zubair-Nizami; Arielle J Weinstein; Mohammad Roky; Kristi L Frank
Journal:  Antimicrob Agents Chemother       Date:  2022-04-21       Impact factor: 5.938

Review 2.  Lactoferrin for prevention of neonatal sepsis.

Authors:  Christie G Turin; Alonso Zea-Vera; Alonso Pezo; Karen Cruz; Jaime Zegarra; Sicilia Bellomo; Luis Cam; Raul Llanos; Anne Castañeda; Lourdes Tucto; Theresa J Ochoa
Journal:  Biometals       Date:  2014-06-17       Impact factor: 2.949

3.  Lactoferrin Disaggregates Pneumococcal Biofilms and Inhibits Acquisition of Resistance Through Its DNase Activity.

Authors:  Uriel A Angulo-Zamudio; Jorge E Vidal; Kamran Nazmi; Jan G M Bolscher; Claudia Leon-Sicairos; Brenda S Antezana; Adrián Canizalez-Roman; Nidia León-Sicairos
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

Review 4.  Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.

Authors:  Daniela Zarzosa-Moreno; Christian Avalos-Gómez; Luisa Sofía Ramírez-Texcalco; Erick Torres-López; Ricardo Ramírez-Mondragón; Juan Omar Hernández-Ramírez; Jesús Serrano-Luna; Mireya de la Garza
Journal:  Molecules       Date:  2020-12-08       Impact factor: 4.411

Review 5.  Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Authors:  María Escobar-Salom; Gabriel Torrens; Elena Jordana-Lluch; Antonio Oliver; Carlos Juan
Journal:  Biol Rev Camb Philos Soc       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.